Introduction
Request documents in three stages: verify the manufacturing site before supplier selection, approve the product specification before production, and check evidence for the actual batch before shipment. Add destination-market documents after confirming the product category with the local responsible party. A factory certificate, an ingredient certificate of analysis and a finished-product release record answer different questions.
Start with a document register rather than an unsorted request for “all certificates.” For each item, identify the product or site it covers, the version or lot number, the decision it supports, who will review it and when it is due. The aim is a traceable approval process, not the largest folder of PDFs.
Ask for the evidence when it can support a real decision
| Project stage | Documents to discuss | Decision they support | Common mismatch to resolve |
|---|---|---|---|
| Supplier screening | Legal-entity details, actual production-site details, relevant licenses and manufacturing credentials | Whether the proposed party and site fit the project | A sales-company document presented as the production site's credential |
| Formula and sample approval | Versioned formula and finished-product specification, ingredient specifications, sample assessment record | What the supplier is proposing and what the buyer is approving | An ingredient specification used as the finished-product specification |
| Production authorization | Approved packaging and label versions, agreed testing plan, quality responsibilities and change process | Which controlled instructions and acceptance criteria apply | A revised formula paired with an older label or testing plan |
| Batch release and shipment | Actual-lot analysis, agreed release evidence, lot-linked packing and commercial documents | Whether the supplied lot matches the agreed product and order | A representative report from another lot used as shipment evidence |
This is a procurement framework. It does not mean that every document is legally mandatory in every country, or that every supplier must disclose its complete proprietary production records to a buyer.
Verify the legal entity and the actual manufacturing site
Ask who will manufacture, test, pack, contract and export the product. Record the legal names and addresses for the relevant roles. Where different entities are involved, request a clear explanation of responsibilities and the relationship supporting the proposed work. Do not resolve an unexplained mismatch by assuming that similar company names refer to the same site.
For a manufacturing license or quality-system certificate, review the complete document and relevant annexes. Check the named holder, site address, covered activities or dosage forms, issuer, dates and current status through the appropriate issuing or verification channel. A certificate for a different address or activity needs an explanation before it can support this project.
Ask about outsourced steps that affect your product and the evidence available for their control. Record any unresolved scope question. A credential can help assess a site or system; it does not establish that a particular formula, label or batch is acceptable for your destination.
The quality discussion with Bodakang Bio should therefore start with the product and market requirements. Request confirmation of the documents available for the specific proposal rather than assuming that a general website description guarantees a particular certificate or submission package.
Approve a finished-product specification, not just an ingredient sheet
A useful product approval file identifies the formula version, dosage form, serving basis, declared contents, pack configuration and agreed acceptance criteria. Ask the technical team to explain which parameters will be assessed, by what methods and on what sampling or verification basis. An unfamiliar abbreviation or unspecified test method should be clarified before it becomes a contractual requirement.
Keep ingredient and finished-product records distinct. An ingredient's identity and composition can inform formulation decisions, but its certificate of analysis does not demonstrate the finished blend's uniformity, the filled capsule's declared contents or the final pack's suitability. Ask how ingredient evidence connects to the proposed product and its release criteria.
For U.S.-bound dietary supplements, the manufacturing framework distinguishes component, in-process, finished-product and packaging specifications. Use that distinction to frame the discussion; do not present a U.S. framework as a universal overseas approval system.
Connect sample approval to the same specification version. Record what the sample was assessed for and what remains unverified. Approval of taste, capsule appearance or bottle artwork should not silently become approval of every analytical parameter or commercial-production condition.
Read a certificate of analysis as evidence with a defined scope
Before reviewing the results, establish what was tested: an ingredient, a development sample, a bulk product or the finished packed batch. Then check the sample or product identifier, lot number, specification reference, report dates, tested parameters, methods, units, acceptance limits and reported results. Ask which party issued the document and who authorized its release.
A “pass” statement without a clear criterion or test scope may not answer your purchasing question. Where a result is numerical, check that the units and reporting basis match the specification. Where a result is qualitative, ask what the stated outcome means. Do not interpret an untested parameter as a confirmed pass.
For a U.S.-bound project, reliance on a component supplier's certificate of analysis is subject to qualification and verification conditions; it is not an unrestricted alternative to evaluating the material. This is also a useful buyer question: how does the manufacturer establish and maintain confidence in the incoming evidence it uses?
If an external laboratory report is supplied, review the laboratory's relevant accreditation scope where applicable, not only its logo. Confirm that the sample, matrix and method relate to your question, and verify report authenticity through a trusted laboratory contact if needed. Accreditation does not turn one tested sample into a guarantee for every future lot.
At screening, a suitably redacted representative report can show the format and scope of evidence available. At shipment, request the agreed evidence for the actual supplied lot. Label representative, preliminary and final documents clearly so they cannot be confused.
Agree access to manufacturing and release records
A master manufacturing record describes the controlled manufacturing instructions; a batch production record documents execution for a particular batch. In the U.S. dietary-supplement framework these have separate requirements, including product and component details in the master record and batch identifiers, processing and testing evidence in the batch record.
That distinction does not itself give a customer unrestricted access to another company's confidential records. Agree what the manufacturer will provide, what can be reviewed under confidentiality arrangements, and what remains in its controlled system. A product-specific summary, agreed audit access or selected records may be appropriate depending on the transaction and regulatory needs.
Before authorizing production, document responsibility for approving specifications, changes, deviations and final disposition. Specify which release evidence must be available before shipment and who will review it. If a batch has been reprocessed, repacked or subject to a material deviation, ask how the agreed evidence addresses that history.
For an OEM/ODM project, include these responsibilities in the scope discussion. An order quantity and unit price alone leave the evidence-delivery obligations undefined.
Request the basis for shelf life and the intended packaging
Ask for a stability summary or other justified evidence that identifies the formula, package, conditions, evaluated parameters, study status and basis for the proposed dating. Distinguish completed results from ongoing work and future commitments. A raw-material expiry date or a study for another package should not automatically become the retail product's shelf life.
Request the agreed primary-pack specification and final label proof alongside the product record. Review the pack size, contact materials, closure or seal configuration and lot/date-code location as relevant to the project. Ask which changes would require renewed evaluation. The important document connection is between the evidence and the pack actually being ordered.
For a U.S.-bound supplement, the manufacturing guidance does not provide a universal expiry period; a dating statement used should have supporting data. Other destinations may impose additional or different stability expectations. Have the responsible reviewer establish those requirements before relying on a proposed expiry date.
Build a separate destination-market document list
Confirm classification first. A food powder, a health supplement and a medicinal product may follow different routes even when some ingredients overlap. The following checkpoints were verified on 27 October 2026 and do not replace a product-specific submission review.
- Indonesia: For imported health supplements, check the manufacturing evidence and applicable equivalence route with the local applicant. The official guidance addresses site and dosage-form scope and, in relevant circumstances, supporting site information and certificate-language requirements. Ask the applicant to confirm the exact document names, issuer and format needed for this product. Do not assume an unrelated quality-system certificate automatically substitutes for accepted manufacturing evidence.
- Thailand: For products following the food route, distinguish the Thai import-premises authorization from the applicable product-permission process. The importer should confirm the manufacturing-system evidence, product-quality information and other documents needed for the category. A foreign supplier's certificate is not the Thai importer's license.
- Singapore: Products classified as health supplements are not subject to the same approval route as medicines. Dealers remain responsible for safety, quality and labeling, and supporting information should be held to demonstrate compliance. Voluntary notification should not be described as product approval. Confirm classification separately for products presented as foods or beverages.
Where a free-sale document, authorization letter, translation, legalization or halal evidence is requested, obtain a written, product-specific checklist from the responsible local reviewer. Check the issuer, covered entity or product, intended use and acceptance conditions. Do not order a document merely because its name appears on another country's checklist.
Make shipment documents match the physical lot
Agree the final document set before dispatch: product and pack version, lot-linked analysis and release evidence, packing list, invoice and any applicable origin, transport or destination documents. Reconcile names, quantities, batch identifiers and pack configurations across the set. Record who resolves discrepancies and whether shipment must wait for the correction.
Protect document integrity during review. Keep the received original file, request a corrected version from its issuer when necessary, and record which version was approved. Do not edit a report or certificate to make it match an order. Where confidential information is redacted, ensure the remaining evidence still answers the intended question or arrange controlled review.
Send a document brief with your manufacturing inquiry
Tell Bodakang Bio the destination country, proposed category, product direction, formula and pack status, expected quantity and the decision each requested document must support. Attach the local reviewer's checklist if you have one. Mark each item as needed for supplier selection, production approval, registration or shipment, with its required timing.
Use the project inquiry page to ask which records are available, which must be generated for the proposed product, what requires a separate service or confidentiality arrangement, and what remains to be confirmed. Availability, scope, charges and timing should be agreed for the individual project; a document request is not a promise that every certificate or dossier can be supplied.
